Table 2: Clinical characteristics and pharmacotherapy of the 106 patients.

Clinical characteristics

Age (Years)61.8 ± 9.9
Male (%)98 (92.5)
Body mass (kg)78.7 ± 13.7
Peak VO2  (ml·kg−1·min−1)16.9 ± 4.4
Diabetes (%)11 (10)
Previous myocardial infarction (%)86 (81)
Atrial fibrillation (%)27 (26)
NYHA class II/III49/57
LVEF (%)30 ± 6.9

Medications

Beta-blocker (%)44 (42)
ACE-inhibitor/antagonist (%)95 (90)
Digoxin (%)67 (63)
Nitrates (%)40 (38)